SLC7A11 and fibrosarcoma: Consistent with previous results [10, 11], we found that genes up-regulated in response to sorafenib were enriched in a ferroptosis-related gene signature from human fibrosarcoma cells treated with the selective xCT inhibitor erastin (Fig. 2A) [23].